Engineering

Reliability engineering

Erythema

Downtime

Surgery

Medicine

Journal of the European Academy of Dermatology and Venereology

Background The frequency of dermatological procedures is steadily increasing, accompanying a growing demand from patients. Chemical peels are a method of resurfacing in the treatment of various skin conditions. However, during the early healing process, patients may impose downtime on themselves. The erythema, pain and poor aesthetic appearance of the skin can lead to unwillingness to participate in social or professional activities. Objectives The objective of this study was to evaluate the tolerance and efficacy of a repair cream based on Rhealba Oat plantlets extract and active healing compounds after a peeling procedure. Methods Men and women, aged 18–65 years, with Fitzpatrick phototype I‐ IV , who had previously received a medium‐depth chemical peel on the face ( TCA 30%) entered with their consent a clinical study evaluating the new test product based on Rhealba Oat and active healing compounds. At the beginning of the study, the selected patients received a TCA 30% medium‐depth peel. Afterwards, they were treated during 29 days with the repair cream and evaluated for the benefits to downtime and pain. Results Significant reductions of pain ( P &lt; 0.0114) and erythema ( P &lt; 0.0001) were observed in the study. The downtime reduction with the tested cream was 92% ‐ from 9 days after the previous peeling procedure to 0.74 days with application of the tested cream – a difference of 8.39 days. Conclusion In consequence, the tested repair cream based on Rhealba Oat plantlets extract and active healing compounds brings clinical benefit to patients who undergo peeling procedures. By reducing pain and downtime, it allows patients to get back to their daily life activities a week earlier than with previous peels.

Efficacy of a repair cream based on Rhealba Oat plantlets extract and active healing compounds in peelings: benefit to patient's downtime and pain